Hypercholesterolemia
Progress slows in lowering cholesterol
Published in Medical Letter on the CDC and FDA, May 25th, 2003
High blood cholesterol is a major risk factor for coronary heart disease and stroke. A total cholesterol level <200 mg/dL signifies a lower risk for heart disease. Total cholesterol of 240 mg/dL or above is considered high. A person with this level may have more than twice the risk of heart disease as someone whose cholesterol is below 200 mg/dL.
"Our data indicate that the trend in population decreases in total cholesterol concentration seems to have markedly slowed," said Earl S. Ford, MD, MPH, a medical officer in the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Trichomonas Vaginalis
Tinidazole effective against metronidazole-resistant Trichomonas vaginalis - Attention Deficit Hyperactivity
Early behavioral development varies among rat strains - Attention Deficit Hyperactivity
Variation in activity levels in rat strains limit their usefulness - Nutrition
HHS and NCI launch national campaign to address diet in African American men - Stem Cell Research
Graft-versus-host specific T-cell clone identified in stem cell transplantation - Antimalarial Analysis
Conductometric and indirect AAS determinations described - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
